Pricing Log in Create free account

GRI Bio, Inc. (GRI) vs Revelation Biosciences, Inc. (REVB)

GRI Bio, Inc. and Revelation Biosciences, Inc. are both Biotechnology companies. GRI Bio, Inc. and Revelation Biosciences, Inc. are of similar size ($3.1M and $3.0M). Revelation Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; GRI Bio, Inc. trades at 0.0×. Across the 9 metrics below, GRI Bio, Inc. leads on 6 and Revelation Biosciences, Inc. on 3.

Valuation

Metric GRI REVB Biotechnology median
P/E 0.02 n/m 8.50
P/S n/m n/m 9.71
P/B 0.24 0.18 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.86 0.86 0.64
EV/Sales n/m n/m 9.21
Earnings yield 5,408.03% (2,564.58%) (33.15%)
Free cash flow yield (418.56%) (513.59%) (25.50%)

Profitability

Metric GRI REVB Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (142.02%) (276.43%) (56.36%)
Return on assets (113.27%) (214.63%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GRI REVB Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 92.12% 97.72% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GRI REVB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.30 6.21 4.72
Net debt to EBITDA 0.69 1.18 0.96

Dividend

Metric GRI REVB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GRI REVB Biotechnology median
Market cap 3.06m 3.04m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack